Clinical Trial | Pemigatinib by Incyte. FIGHT202. It's an FGFR2 inhibitor drug.

Scottsdale
Scottsdale Member Posts: 1
edited December 2022 in Bile Duct (Cholangiocarcinoma) Cancer
This is an FGFR2 inhibitor. If you have bile duct cancer, you should have NGS(next generation sequencing) either through biopsy or a blood test(liquid biopsy) to determine if your tumor has a mutation that is able to be targeted by a specific treatment.

Categories